Tanya Troy
Research Subjects
Tanya Troy has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Carole Fakhry
Department of Otolaryngology-Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland
21 shared publications - Cecile Delille Lahiri
Division of Infectious Diseases, Department of Medicine Emory University School of Medicine Atlanta Georgia USA
21 shared publications - Dorothy J. Wiley
School of Nursing, University of California Los Angeles, Los Angeles, CA, USA
21 shared publications - Frank Joseph Palella
Division of Infectious Diseases, Northwestern University Feinberg School of Medicine , Chicago, Illinois
21 shared publications - Gypsyamber D'SOuza
Johns Hopkins University 8 Baltimore, Maryland
21 shared publications - Howard D. Strickler
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York
21 shared publications
Latest Publications
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 3: Effect of age on prevalent (SF3a) incident (SF3b) infections.
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 3 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 3: Effect of age on prevalent (SF3a) incident (SF3b) infections.
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 2: Clearance of prevalent (panel A) and incident (panel B) oral HPV16 infections over 10 years
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 2: Clearance of prevalent (panel A) and incident (panel B) oral HPV16 infections over 10 years
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 4: Effect of sex on prevalent (SF4a) incident (SF4b) infections.
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 4 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 4: Effect of sex on prevalent (SF4a) incident (SF4b) infections.
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 6: Effect of HIV and CD4 on prevalent (SF6a) incident (SF6b) infections.
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 6 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 6: Effect of HIV and CD4 on prevalent (SF6a) incident (SF6b) infections.
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 7: Effect of HPV type (16 vs non16 oncogenic HPV type) on prevalent (SF7a) incident (SF7b) infections.
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 7: Effect of HPV type (16 vs non16 oncogenic HPV type) on prevalent (SF7a) incident (SF7b) infections.
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 7: Effect of HPV type (16 vs non16 oncogenic HPV type) on prevalent (SF7a) incident (SF7b) infections.
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 7 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 7: Effect of HPV type (16 vs non16 oncogenic HPV type) on prevalent (SF7a) incident (SF7b) infections.
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 1: Proportion of 1833 subjects screened who have oncogenic oral HPV DNA and cancer characteristics.
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 1: Proportion of 1833 subjects screened who have oncogenic oral HPV DNA and cancer characteristics.
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 5: Effect of HPV16 qPCR copynumber(CN) per cell on HPV16 infections.
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 5 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 5: Effect of HPV16 qPCR copynumber(CN) per cell on HPV16 infections.
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 2: Multivariate predictors of clearance, across the four different clearance definitions evaluated in this study.
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Table 2 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Table 2: Multivariate predictors of clearance, across the four different clearance definitions evaluated in this study.
- Open Access
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Supplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 1: Flowchart of the 1833 MACS and WIHS participants in the POPS, how many had oncogenic oral HPV DNA, and how many had additional follow-up of uncleared infections as part of the MOUTH study.
- 3 April 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplemental Figure 1 from Oncogenic Oral Human Papillomavirus Clearance Patterns over 10 Years
Supplemental Figure 1: Flowchart of the 1833 MACS and WIHS participants in the POPS, how many had oncogenic oral HPV DNA, and how many had additional follow-up of uncleared infections as part of the MOUTH study.